Related Experiment Video
Updated: Jul 18, 2026

In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages
Published on: December 30, 2017
Microneedle delivery of CAR-M-like engineered macrophages alleviates intervertebral disc degeneration through
Xingyu Zhou1, Dingchao Zhu1, Di Wu1
1Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Abstract:
Macrophages eliminate apoptotic cells produced daily in the body through efferocytosis. Restricted clearance can cause inflammation-related diseases. In intervertebral discs (IVDs), apoptotic nucleus pulposus cells (NPCs) are difficult to effectively remove, and their accumulation can cause changes in the inflammatory microenvironment, disrupt IVD homeostasis, and lead to IVD degeneration (IDD). Here, we present chimeric antigen receptor-M-like engineered macrophages (CAR-eMs) with enhanced efferocytosis capacity for IDD treatment. Macrophages undergo phenotypic transformation and a reduction in phagocytic ability after phagocyting apoptotic NPCs, but their efferocytosis capacity recovers with upregulated brain-specific angiogenesis inhibitor 1 (BAI1) expression. We develop a CAR-eM system with enhanced BAI1 expression and an IVD circular microneedle (MN) delivery system that utilizes arrays of MNs to deliver CAR-eMs into the deep IVD layers, thereby clearing apoptotic NPCs, ameliorating the inflammatory microenvironment, and repairing damaged IVDs. Our study explores the therapeutic potential of CAR-eM efferocytosis for IDD treatment.
Insights
Engineered macrophages with enhanced efferocytosis clear apoptotic cells in intervertebral discs (IVDs). This novel approach using chimeric antigen receptor-M-like engineered macrophages (CAR-eMs) offers a promising treatment for intervertebral disc degeneration (IDD).
Area of Science:
- Immunology
- Regenerative Medicine
- Biomaterials
Background:
- Macrophages perform efferocytosis to clear apoptotic cells, preventing inflammation-related diseases.
- Accumulation of apoptotic nucleus pulposus cells (NPCs) in intervertebral discs (IVDs) disrupts homeostasis and causes intervertebral disc degeneration (IDD).
- Macrophage efferocytic capacity diminishes after phagocytosing NPCs, hindering effective clearance in IVDs.
Purpose of the Study:
- To develop engineered macrophages with enhanced efferocytosis for treating IDD.
- To investigate the role of brain-specific angiogenesis inhibitor 1 (BAI1) in macrophage efferocytosis recovery.
- To create a novel delivery system for engineered macrophages into deep IVD layers.
Main Methods:
- Development of chimeric antigen receptor-M-like engineered macrophages (CAR-eMs) with upregulated BAI1 expression.
- Design of a circular microneedle (MN) delivery system for targeted CAR-eM delivery into IVDs.
- Evaluation of CAR-eM efferocytosis capacity and therapeutic efficacy in an IDD model.
Main Results:
- CAR-eMs demonstrated enhanced efferocytosis of apoptotic NPCs.
- Upregulated BAI1 expression restored and enhanced macrophage efferocytic function.
- The MN delivery system successfully delivered CAR-eMs to deep IVD layers, clearing apoptotic NPCs.
- Treatment with CAR-eMs ameliorated the inflammatory microenvironment and promoted IVD repair.
Conclusions:
- Engineered macrophages (CAR-eMs) with enhanced BAI1 expression show significant potential for treating IDD by improving efferocytosis.
- The microneedle delivery system provides an effective method for targeted delivery of therapeutic macrophages into the IVD.
- This study presents a promising cell-based therapy for intervertebral disc degeneration by leveraging enhanced efferocytosis.
More Related Videos
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

